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Background: Environmental pollutants are thought to be one of major triggers of atopic dermatitis (AD).
Objective: We attempted to evaluate the clinical effects of environment with low indoor pollutant levels on AD management. 
Methods: Fifty-one children (mean age 1.7 years) with moderate to severe AD who failed to show improvement with conventional 
management were recruited. Disease severity was assessed by SCORAD (Scoring of AD) indices. They were admitted in a low pollutant 
oom for 3-4 days (mean 3.3 days) which was designed to keep low levels of dust, house dust mites, micro-organisms, and indoor 
air pollutants such as total volatile organic compounds (TVOCs), particulate matter (PM), and so on. Air pollutant levels in the low 
pollutant room were lower than primary standards defined by the Korean Ministry of Environment. we compared disease severity on 
admission and after discharge, and the pollutant levels of each patient’s home and low pollutant room. 
Results: The SCORAD was significantly reduced from 42.0 ± 11 .5 to 29.8 ± 8.9 (p < 0.001) by management in a low pollutant room. 
PM2.5 , PM10, formaldehyde, TVOCs, carbon dioxide, bacterial suspensions, and indoor molds were significantly higher in the patient’s 
home than low pollutant room. Out of 29 patients who deteriorated after discharge to their home, 8 patients were admitted again, 
and their SCORAD was rapidly decreased from 53.1 ± 16.2 to 39.2 ± 9.8 (p = 0.036). 
Conclusion: Indoor air pollutants are likely to affect AD in susceptible individuals. Environmental control to lower indoor air pollutant 
levels might be necessary for better management of AD in some patients.
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Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin 
disease and is one of the most common allergic diseases in 
children. The prevalence of AD has recently increased worldwide, 
with an incidence of 10-20% of children in Westernized countries 
[1]. Although AD has been correlated with hereditary factors [2-
4], the rapidly growing incidence of AD in recent years cannot 
be explained by genetic factors alone. In other words, the 
mechanisms for AD development involve complex interactions 
between susceptibility genes and environmental factors [5-8]. 
The role of the indoor environment in the development of AD 
has been studied. For example, a recent study reported that indoor 
redecoration activities before birth and in the first years of life are 
associated with the development of AD in early childhood [9]. 
Exposure to volatile organic compounds (VOCs) can damage the 
epidermal barrier and enhance adverse effects of house dust mites 
on sensitized subjects with AD [10]. Formaldehyde and nitrogen 
dioxide (NO2) at domestic concentrations cause skin barrier 
function impairment in patients with AD [11]. Environmental 
pollutants seem to activate non-specific inflammation, lead to 
mechanical responses, or modify the T helper (Th) 2 response to 
allergens [12]. In addition, Staphylococcus aureus is also thought to 
be one of the major environmental triggers of AD [13].
Although previous studies have been carried out to identify 
adverse environmental effects on AD symptoms [9-11], few 
reports have been published regarding the relationship between 
the indoor air pollutant levels and AD symptoms. Therefore, we 
performed this study to evaluate clinical effects of an indoor 




In this study we recruited 51 children with AD whose symptoms 
did not improve with conventional management in our outpatient 
clinic. Out of 51 children, 52.9% of patients have family histories of 
allergy. In past medical history, 4.9% of patients have diagnosed 
with asthma, and 47% had food allergy. About 82% (42 children) 
were breastfed; the mean duration of breastfeeding was 7.7 
months (Table 1).
AD was diagnosed by using Hanifin and Rajka’s criteria [14], 
and the severity of AD was assessed by the SCORAD (SCORing of 
Atopic Dermatitis), ranging from 0 to 103 [15]. Those who were 
enrolled in this study had moderate to severe AD, which was 
determined by SCORAD indices ≥ 15. AD severity was assessed 
on the day of hospitalization, at discharge and in the outpatient 
clinic within a month after discharge. This study was approved by 
the Institutional Review Board of Samsung Medical Center, and 
written informed consent was obtained from all parents prior to 
participation in this study.
Low pollutant room
We prepared a low pollutant room in our pediatric wards which 
was designed to have low levels of dust, house dust mite, micro-
organisms, and indoor air pollutants such as total VOCs (TVOCs), 
formaldehyde, carbon monoxide (CO), carbon dioxide (CO2), and 
NO2. The room was constructed and decorated with environment-
friendly building materials. In addition, an air curtain (Spi System; 
Samsung Electronics, Korea) was installed above the entrance, and 
an air purifier-ventilator (Indoor Air Quality, IAQ100DV; Samsung 
Electronics, Korea) was put in the room. 
Patients were admitted to the low pollutant room for 3-4 days 
(mean 3.3 days). During admission, they were educated and 
managed according to the guideline developed in our hospital. 
During stay in the low pollutant room, systemic anti-inflammatory 
treatment was not used, even in severe patients.  After discharge, 
they were instructed to continue management in the same way 
they did in the hospital. 
Indoor air quality measurement
We assessed indoor air quality by measuring the levels of known 
pollutants in the indoor environment, such as particulate matter 
(PM2.5 and PM10), formaldehyde, TVOC (benzene, toluene, ethyl-
benzene, xylene, and styrene), CO, CO2, NO2, bacterial suspension, 
Table 1. Demographic characteristics of the participants (n = 51)
Parameters  Number of patients (%)
Age (years, mean ± SD) 1.68 ± 2.51
Sex (male) (%) 34 (67.0)
Breastfeeding (%) 42 (82.3)
Breastfeeding duration (months, mean ± SD) 7.69 ± 4.35
Family history of allergic diseases (%) 27 (52.9)
Diagnosis of asthma (%) 2 (4.9)
Diagnosis of food allergy (%) 24 (47.0)apallergy.org
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and indoor molds in the low pollutant room regularly once a 
week. Indoor air quality in the living room of each patient’s home 
was also assessed in the same way. These measurements were 
performed according to the guideline of the Korean Ministry 
of Environment [16]. Primary standards for particulate matter, 
formaldehyde, TVOC, and those for bacterial suspension were also 
defined by the guideline of the Korean Ministry of Environment 
[17]. In addition, the standard for indoor molds was decided 
according to the World Health Organization (WHO) [18].
Statistical analyses
Data were statistically analyzed with SPSS version 13.0 (SPSS, 
USA). Wilcoxon Signed Rank test was used to compare SCORAD 
indices before and after hospitalization. The t test and analysis of 
variance were applied to compare the pollutant levels of patients’ 
homes and the low pollutant room. A p value less than 0.05 was 
considered to be statistically significant. 
RESULTS 
Out of 51 children (males: 34, females: 17), the mean age was 1.7 
years old. The SCORAD was reduced from 42.0 ± 11.5 to 29.8 ± 8.9 
by hospitalization in the low pollutant room. The Wilcoxon Signed 
Rank test showed significant improvements of symptom scores in 
patients with AD (p < 0.001, Fig. 1).
Analyses of individual environmental factors, such as PM2.5 (p 
< 0.001), PM10 (p < 0.001), formaldehyde (p < 0.001), TVOCs (p < 
0.001), styrene (p = 0.004), CO2 (p < 0.001), bacterial suspensions 
(p < 0.001), and indoor molds (p < 0.001) showed significantly 
higher levels in patients’ rooms compared to the low pollutant 
room. There was no significant statistical difference in the levels of 
benzene, toluene, ethyl-benzene, xylene, CO and NO2 (Table 2). 
At the first out-patient clinic visit within a month after discharge, 
out of 51 patients, 22 patients maintained the improvement in 
their symptoms, but skin lesions of the remaining 29 patients 
were aggravated. Excluding 3 patients who had clear reasons 
for aggravation such as ingestion of restricted food, herpes virus 
infection, and the contact with irritants, we divided 48 patients 
into two groups, the improved and aggravated groups, after 
discharge. No statistical significance of indoor environment was 
shown between the aggravated and improved groups (Table 3).  
Out of 29 patients in the aggravated group, 8 patients were re-
admitted to the low pollutant room, and their SCORAD indices 
rapidly decreased from 53.1 ± 16.2 to 39.2 ± 9.8 (p = 0.036). Out of 
8 patients, 4 patients had recently undertaken indoor renovation 
activities; 2 patients had performed house painting, and 2 
patients had replaced wallpaper. Among 8 patients, 6 patients 
live in apartments, while 2 patients reside in row houses. Current 
paternal smoking and wall molds were found in 4 and 3 patients, 
respectively. Two patients lived between 200 m and 500 m away 
from major thoroughfares with four or more lanes, while five 
patients lived less than 200 m away.
DISCUSSION
We hypothesized that AD symptom severity might be affected 
by the indoor environment. If there are AD patients who are 
exposed to inappropriate home environment in terms of indoor air 
quality, their symptoms would be controlled more effectively in a 
low pollutant environment and might be aggravated again when 
they are re-exposed. We selected AD patients whose symptoms 
did not improve by conventional treatment in outpatient clinic 
because they could be possible candidates. We attempted to 
observe the differences in change of symptom severity and 
compared indoor air pollutant levels between their home and 
the low pollutant room. As a result, we found in this study that 
some patients showed alteration in their symptom severity by the  Fig. 1. Atopic dermatitis severity score before and after hospitalization.apallergy.org




change in indoor air pollutant levels, although our hypothesis is 
not applicable in all patients.
Previous studies have shown that indoor environmental factors 
increase the risk for AD and allergic diseases. Herbarth et al. [9] has 
reported that participants experiencing recent indoor renovation 
show a high odds ratios of 1.9 (95% CI: 1.4-2.7) for eczema. They 
also reported that inflammatory response mediators such as 
interleukin (IL)-8 and monocyte chemoattractant protein-1 in 
children’s blood increased when renovations were conducted 
[19]. Lehmann et al. [20] demonstrated that exposure to indoor 
VOCs may differentiate T cells into responsive Th2 cells. In addition, 
even the typical domestic concentration of formaldehyde can 
cause skin barrier function impairment in patients with AD [11]. A 
moderate increase in long-term exposure to background ambient 
air pollutants, such as ozone and PM10, was associated with an 
increased prevalence of AD in children [21]. However, these 
previous investigations have been limited by a lack of evidence 
showing clinical effects of the environment with low levels of 
pollutants on atopic diseases.
Other than chemical pollutants, a strong association between 
indoor bioaerosols and AD severity has been reported. Higher 
levels of environmental S. aureus may contribute to disease 
severity and persistence in AD patients [13]. Molds on indoor walls 
increased the risk of early infantile AD [5], and dampness in the 
child’s home may be an important risk factor for AD [8]. The itching 
in AD is significantly dependent on meteorological conditions [22]. 
However, others reported that the risk for AD is higher in children 
living in damp homes but this trend did not reach statistical 
significance [23]. Patients with AD have skin barrier dysfunction 
and increased transepidermal water loss. This impairment of skin 
barrier function causes increased allergen absorption, which 
contributes to the cutaneous hyper-reactivity of AD [24]. 
In this study, only a small number of patients participated, 
and treatment during hospitalization was not well controlled. 
In addition, some patients showed association between clinical 
symptoms and indoor air pollutant levels, while others did not. 
Therefore, it is too early to conclude that control of indoor air 
quality is mandatory for the management of AD. However, our 
hypothetical experience suggests that better indoor environment 
helps to improve AD symptoms in a certain group of patients. 
PM2.5, PM10, TVOCs, formaldehyde, indoor bacterial aerosols, and 
indoor molds might be responsible for aggravation of AD lesions in 
these susceptible individuals. If it is true, an effort should be made 
to minimize exposure to indoor air pollutants using a ventilation 
system, air cleaner, and environmentally friendly materials for 
better management of AD. 
Table 2. Comparison of indoor air quality between the patient’s home and low pollutant room
Variables Primary standards
Low pollutant room
 (N = 87)
Patient’s home
(N = 48) p value
GM ± GSD GM ± GSD
PM10 (µg/m
3) 100 46.9 ± 1.4 63.0 ± 1.4 <0.001
PM2.5 (µg/m
3) 35 29.2 ± 1.3 48.8 ± 2.0 <0.001
Formaldehyde (µg/m
3) 100 26.1 ± 1.5 57.6 ± 1.8 <0.001
TVOCs (µg/m
3) 400  288.9 ± 1.5  433.1 ± 1.6 <0.001
    Benzene 30 1.98 ± 1.5 1.99 ± 1.8 0.629
    Toluene 1,000 46.5 ± 1.8 55.4 ± 2.1 0.135
    Ethyl-benzene 30    5.36 ± 1.9 5.70 ± 1.8 0.980
    Xylene 700    10.3 ± 1.7 10.4 ± 1.7 0.436
    Styrene 300    1.36 ± 1.7 2.20 ± 2.2 0.004
CO (ppm) 10    0.61 ± 2.2 0.72 ± 2.1 0.107
CO2  (ppm) 1,000  677.9 ± 1.2  826.3 ± 1.4 <0.001
NO2 (ppm) 0.05  0.013 ± 1.7  0.016 ± 2.1 0.079
Bacterial aerosols 800  176.2 ± 2.1  603.5 ± 1.9 <0.001
Indoor molds (CFU/m
3) 150    33.1 ± 1.7  107.6 ± 2.8 <0.001
t-test was used to compare the indoor air pollutant level between low pollutant room and patient’s home. GM: geometric mean, GSD: 
geometric standard deviation, TVOCs: total volatile organic compounds, CFU: colony forming unit.apallergy.org
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In conclusion, indoor air pollutants are likely to affect AD in 
susceptible individuals. Environmental control to lower indoor air 
pollutant levels might be necessary for better management of AD 
in some patients. Further research is required to clarify the role of 
indoor air quality in improving or aggravating AD symptoms.
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